Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.

Latest News

Sorting:
  • Archangels Heralds Further Year of Support for Scottish Businesses

    Archangels lead £14.8m of investment in 2019 Edinburgh | December 2019 Archangels has recorded another active year of support, leading investment of £14.8m in Scottish start-up and early stage companies in the tech and life sciences sectors. The syndicate directly invested £8.2m across the year (2018: £10.9m) and was lead investor on a total of […]

  • Archangels Sells Critiqom Stake into Company Sale

    Archangels has sold its 23% shareholding Edinburgh | 20 December 2019 As part of the sale of Critiqom to Opus Trust Communications, Archangels has sold its 23% shareholding in the document outsourcing specialist. Archangels first invested in Critiqom in 2005 and since then the company has grown to become a national provider of a variety […]

  • Speech Graphics Win Tech Start-up of the Year

    Speech Graphics – Tech Startup of the Year 2019 Edinburgh | 29 November 2019 We are delighted for our portfolio company, Speech Graphics who have been named the Startup of the Year at the Scottish Tech Startup Awards 2019. The Scottish Tech Startup Awards returned to Edinburgh to continue to recognise excellence in the Scottish […]

  • Interview with CEO of Optos, a former Archangel Backed Company

      The Big Interview: Optos chief executive Robert Kennedy The Scotsman | 02 December 2019 Optos was supported by Archangels from 1992 until its stock market flotation in 2006. The multi-award winning company is now internationally recognised as the leading provider of devices to eyecare professionals. Link to full article  

  • New CALCiViS Funding to Support Pre-Market Approval in USA

      CALCiViS Announces Completion of Funding Round The medical devices company, focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has closed the final part of a £4.5 million equity funding round led by Archangels and supported by the Scottish Investment Bank. The proceeds will be used to support the […]

  • New Funding for MGB Biopharma to Complete Clinical Trial

    MGB Biopharma Announces Completion of Funding Round MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance, has announced the completion of its latest funding round. The over-subscribed fund-raise was supported by new and existing investors, led by Archangel Investors and including Scottish Investment Bank […]

Company portfolio

  • Archangel Investors Ltd
  • Archangel Investors Ltd
  • Archangel Investors Ltd

See our ‘Impact evaluation of activities report’ by the Hunter Centre for Entrepreneurship at The University of Strathclyde.